Critical Path Institute (C-Path) hosted this webinar on Wednesday February 25, that brought together drug development leaders for a practical, collaborative discussion on evidence needs, data strategies, opportunities, and approaches to regulatory engagement for individualized and small-population therapies. This “Transforming Drug Development for Precision Medicines” webinar highlighted how precision medicine continues to evolve, explored shared challenges and opportunities in creating more predictable, and how we can align pathways from development through reimbursement.
The themes raised here are already informing next steps behind the scenes. Stay tuned.
You can view the recording below, and be on the lookout for registration details for the next webinar in our series, “Scalable Approaches to Patient-Centered Benefit-Risk: Defining Patient-Focused Drug Development in Precision Medicine,” coming soon in March!
What We Covered:
- Evolving evidence needs for individualized and small-population therapies
- Data strategies that support regulatory and payer decision-making
- Framework and infrastructure opportunities to improve predictability and efficiency
- Practical approaches to early and ongoing regulatory engagement
- Clear next steps for organizations navigating precision medicine development today
